Skip to main content
. 2019 May 1;7:82. doi: 10.3389/fbioe.2019.00082

Table 3A.

Results from participants in the testing of the Roadmap (Part I) of the ‘Guidance on Risk Assessment of LMOs developed by the AHTEG under the Cartagena Protocol on Biosafety, and the answers by the Party countries to questions on risk assessment (see Box 6) in the third national reports3 on implementation of the Protocol, by countries that are currently conducting risk assessments for commercial production.

Q89. YES—Conducting any risk assessments
Q90. YES—Conducting Risk Assessments for Commercial Production
Q85a. Using any guidance Q86. Using AHTEG guidance Roadmap testing results
Avg. score all criteria Number of comments
Party
Norway Yes Yes 5 5
Cuba D Yes Yes 4.75 2
Austria (EU) Yes No 4.75 15
Egypt D 4.75 4
Czech Republic (EU) Yes Yes 4.5 7
Slovenia (EU) Yes No 4.25 0
Spain (EU) Yes Yes 4.25 1
Costa Rica D Yes Yes 4 4
European Union* Yes No 4 7
Germany (EU) Yes No 4 21
Portugal (EU) Yes No 4 0
Mexico D Yes No 4 19
South Africa D Yes No 4 12
Italy (EU) Yes No 3.75 1
Uruguay D Yes No 3.75 2
VietNam D Yes No 3.5 1
Belgium (EU) Yes No 3 5
Colombia D Yes No 2.5 11
Netherlands (EU) Yes No 2.25 7
India D Yes No 2.25 48
Brazil D Yes No 2 27
Honduras D Yes No 2 6
Japan Yes No 2 25
Philippines D Yes No 2 1
Average 3.55 9.6
Other (Non-Party) Governments
Canada 2.5 21
United States 2.25 10
Australia 2 50
Average 2.13 27

“D” denotes developing country or economy in transition status according to the United Nations (2018)2.

*

The European Union participates in the COP-MOPs as a Party, as do the individual member states.